FDA NDC Directory · JSON-LD · Markdown
NDC 73562-111 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE
| Generic name | pancrelipase lipase, pancrelipase protease, pancrelipase amylase |
|---|---|
| Labeler / Manufacturer | Aimmune Therapeutics, Inc. |
| Marketing category | Biologic License Application · App BLA022210 |
| Dosage form / route | CAPSULE, DELAYED RELEASE · ORAL |
| Active ingredients | PANCRELIPASE AMYLASE (63000 [USP'U]/1) PANCRELIPASE LIPASE (15000 [USP'U]/1) PANCRELIPASE PROTEASE (47000 [USP'U]/1) |
| Marketing started | 20201201 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).